When Suniel Shetty starts selling your medicines, you know Bollywood has finally found a franchise that won’t flop. Zota’s DavaIndia chain is expanding faster than momo stalls outside colleges. With 1,745 stores, they’ve practically become the Starbucks of generic pills. But the question is — will these cheap meds deliver premium profits or just give investors a mild headache? Stick around, because the real prescription gets spicier.
2. At a Glance
Revenue up 84% YoY – CFO swears it’s not jugaad, just pill-popping demand.
DavaIndia revenue +111% – Suniel Shetty > Salman Khan’s Being Human T-shirts.
Exports +41% – Even foreign aunties love cheap paracetamol.
EBITDA margin at 4.7% – Barely above homeopathy dosage levels.
Footfalls doubled – From 17.5 lakh to 35 lakh, half came for free BP checks.
19 store closures (lifetime) – Pretty decent survival rate, better than half the startups.
3. Management’s Key Commentary
Quote: “Generic drugs offer same efficacy as branded at 60–90% lower price.” (Translation: Why buy Crocin at ₹30 when our clone works for ₹5?)
Quote: “DavaIndia now has 1,745 stores nationwide.” (Translation: PharmEasy, NetMeds — please move aside, kirana-style invasion mode ON.)
Quote: “Average wallet spend is ₹231 in COCO stores and ₹281 in FOFO.” (Translation: Customers are upgrading from buying just paracetamol to adding shampoo sachets.)
Quote: “EBITDA turned positive due to maturing COCO stores.” (Translation: Our toddlers are finally walking without diapers, profitability diapers in this case.)
Quote: “80% of our customers are repeat buyers.” (Translation: People love discounts so much they come back for BP pills even if they don’t have BP.)
Quote: “We may reach 5,000 stores in 2–3 years.” (Translation: We’re going for an IPL-style land grab. Don’t ask about margins, please.)
Quote: “Advertising will increase moderately.” (Translation: Suniel Shetty doesn’t come cheap, boss.)
4. Numbers Decoded
Source table
Metric
Value Q1FY26
YoY Change
One-Line Analysis
Revenue – The Hero
₹103.6 Cr
+84%
Grew like a steroid shot; mostly DavaIndia-fueled.
EBITDA – Sidekick
₹4.8 Cr
Turned pos.
Margins at 4.7%, barely a paracetamol dose.
Gross Profit – Buffer
₹58.5 Cr
+95%
Healthy jump, COCO stores doing the heavy lifting.
